Kaleido Stock Probability of Future Stock Price Finishing Under 5.67

KLDO -  USA Stock  

USD 5.45  0.07  1.30%

Kaleido Biosciences' future price is the expected price of Kaleido Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kaleido Biosciences performance during a given time horizon utilizing its historical volatility. The Price to Book Value is projected to slide to 13.92. The value of Price to Earnings Ratio is estimated to slide to -4.03.

Search Price Probability 

 
Refresh
Please see Kaleido Biosciences Backtesting, Kaleido Biosciences Valuation, Kaleido Biosciences Correlation, Kaleido Biosciences Hype Analysis, Kaleido Biosciences Volatility, Kaleido Biosciences History as well as Kaleido Biosciences Performance. Please specify Kaleido Biosciences time horizon, a valid symbol (red box) and a target price (blue box) you would like Kaleido Biosciences odds to be computed.
Apply Odds

Kaleido Biosciences Target Price Odds to finish below 5.67

The tendency of Kaleido Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for foresting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 5.67  after 90 days
 5.45 90 days 5.67  about 15.72
Based on a normal probability distribution, the odds of Kaleido Biosciences to stay under $ 5.67  after 90 days from now is about 15.72 (This Kaleido Biosciences probability density function shows the probability of Kaleido Stock to fall within a particular range of prices over 90 days) . Probability of Kaleido Biosciences price to stay between its current price of $ 5.45  and $ 5.67  at the end of the 90-day period is about 11.71 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.7 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Kaleido Biosciences will likely underperform. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Kaleido Biosciences is significantly underperforming DOW.
 Kaleido Biosciences Price Density 
      Price 

Predictive Modules for Kaleido Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kaleido Biosciences. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kaleido Biosciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
2.445.548.64
Details
Intrinsic
Valuation
LowReal ValueHigh
4.347.4410.54
Details
5 Analysts
Consensus
LowTarget PriceHigh
5.0014.6022.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-2.63-2.31-2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kaleido Biosciences. Your research has to be compared to or analyzed against Kaleido Biosciences' peers to derive any actionable benefits. When done correctly, Kaleido Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kaleido Biosciences.

Kaleido Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kaleido Biosciences is not an exception. The market had few large corrections towards the Kaleido Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kaleido Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kaleido Biosciences within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.17
β
Beta against DOW2.70
σ
Overall volatility
0.30
Ir
Information ratio -0.12

Kaleido Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kaleido Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kaleido Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kaleido Biosciences generates negative expected return over the last 90 days
Kaleido Biosciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (85.11 M) with loss before overhead, payroll, taxes, and interest of (54.99 M).
Kaleido Biosciences currently holds about 92.36 M in cash with (67.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17.
Kaleido Biosciences has a frail financial position based on the latest SEC disclosures
Over 81.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: End Wells The End in Mind Conference to Explore Psychedelics Role in Improving the End of Life Experience - Yahoo Finance

Kaleido Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kaleido Stock often depends not only on the future outlook of the current and potential Kaleido Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaleido Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out7.94%
Short Percent Of Float16.12%
Float Shares20.94M
Shares Short Prior Month3.25M
Average Daily Volume Last 10 Day103.48k
Average Daily Volume In Three Month252.87k
Date Short Interest28th of May 2021

Kaleido Biosciences Technical Analysis

Kaleido Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Kaleido Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kaleido Biosciences. In general, you should focus on analyzing Kaleido Stock price patterns and their correlations with different microeconomic environments and drivers.

Kaleido Biosciences Predictive Forecast Models

Kaleido Biosciences time-series forecasting models is one of many Kaleido Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kaleido Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Kaleido Biosciences

Checking the ongoing alerts about Kaleido Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kaleido Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Kaleido Biosciences Alerts

Kaleido Biosciences Alerts and Suggestions

Kaleido Biosciences generates negative expected return over the last 90 days
Kaleido Biosciences has high historical volatility and very poor performance
The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (85.11 M) with loss before overhead, payroll, taxes, and interest of (54.99 M).
Kaleido Biosciences currently holds about 92.36 M in cash with (67.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17.
Kaleido Biosciences has a frail financial position based on the latest SEC disclosures
Over 81.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: End Wells The End in Mind Conference to Explore Psychedelics Role in Improving the End of Life Experience - Yahoo Finance
Please see Kaleido Biosciences Backtesting, Kaleido Biosciences Valuation, Kaleido Biosciences Correlation, Kaleido Biosciences Hype Analysis, Kaleido Biosciences Volatility, Kaleido Biosciences History as well as Kaleido Biosciences Performance. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.